ABSTRACT
Background Indoor residual spraying (IRS) is a core insecticide-based vector control tool employed in most malaria-affected settings globally. However, mosquito vectors have developed resistance to nearly all the insecticides currently used in IRS. This has necessitated a transition to new classes of insecticides from mostly using Dichlorodiphenyltrichloroethane (DDT) and pyrethroids from 1997 to 2010, to carbamates from 2011 and organophosphates from 2013. In addition, other vector control measures like the use of long-lasting insecticide-treated bed nets (LLINs) have also been employed for malaria control. Despite the implementation of these mosquito vector control interventions, malaria remains a disease of public health concern especially in sub-Saharan Africa which bears over 90% of the disease burden. This review will thus collate evidence on the effectiveness of IRS for malaria control in sub-Saharan Africa.
Methods and analysis The systematic review will be done following a priori criteria developed using PRISMA guidelines. Articles will be obtained through a search of Medline via PubMed, Scopus, and Embase databases. The Mesh terms and Boolean operators (“AND,” “OR”) will be used in the article search. Additionally, websites of malaria research institutions will be searched. Article search will be done by two independent librarians (AAK and RS). All identified articles will be transferred to Epi-reviewer v6.15.1.0 software. Article screening and data abstraction will be done in duplicate by four reviewers (KO, LN, GK and MO) and any further disagreements will be resolved through discussion and consensus. Data analysis will be done using STATA v17.0. Heterogeneity in the articles will be assessed using the I2 statistic. Publication bias will be assessed using a funnel plot.
Results The findings of this review will help generate evidence on the effectiveness of indoor residual spraying using WHO pre-qualified insecticides in malaria control in sub-Saharan Africa.
This protocol was registered in PROSPERO (https://www.crd.york.ac.uk/prospero/) registration number CRD42024517119
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval is not required for this systematic review and meta-analysis as only a secondary analysis of data publicly available in scientific databases will be conducted. The results of this review will be submitted for publication in a peer-reviewed journal. Additionally, the findings will be presented at relevant conferences.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
Funding: This study is supported by Environmental Science ZA PTY Limited (“Envu”)’ Islando Johannesburg, South Africa. The funder has no role in the design, conduct and publication of the findings of this review.
Competing interests: None declared
Data Availability: The data from this study will be publicly available from the published studies included in the review
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion
